Visualizar Tese - Instituto de Biociências - Unesp
Visualizar Tese - Instituto de Biociências - Unesp Visualizar Tese - Instituto de Biociências - Unesp
Cirilo, PDRREFERÊNCIAS227Scherer SW, Cheung J, MacDonald JR et al. Human chromosome 7: DNA sequence and biology.Science, 300, 767-772, 2003.Schwartz SM. Epidemiology of uterine leiomyomata. Clin Obst Gynecol, 44, 316-326, 2001.Segal E, Shapira M, Regev A et al. Module networks: identifying regulatory modules and theircondition-specific regulators from gene expression data. Nat Genetics, 34, 166-176, 2003.Sell SM, Tullis C, Stracner D et al. Minimal interval defined on 7q in uterine leiomyoma. CancerGenet Cytogenetics, 157, 67–69, 2005.Sendemir A, Sendemir E, Kosmehl H et al. Expression of sex hormone-binding globulin, oxytocinreceptor, caveolin-1 and p21 in leiomyoma. Gynecol Endocrinol, 24, 105-112, 2008.Shaw-Smith C, Redon R, Rickman L et al. Microarray based comparative genomic hybridization(array-CGH) detects submicroscopic chromosomal deletions and duplications in patientswith learning disability/mental retardation and dysmorphic features. J Med Genet, 41, 241–248, 2004.Shiang CY, Qi Y, Wang B et al. Amplification of fibroblast growth factor receptor-1 in breast cancerand the effects of brivanib alaninate. Breast Cancer Res Treat, 123, 747-755, 2010.Shozu M, Sumitani H, Segawa T et al. Overexpression of aromatase P450 in leiomyoma tissue isdriven primarily through promoter I.4 of the aromatase P450 gene (CYP19). J ClinEndocrinol Metab, 87, 2540-2548, 2002.Shaik NA, Lone WG, Khan IA et al. Enhanced transcription of estrogen receptor α and mitochondrialcytochrome b genes in uterine leiomyomas. Gynecol Endocrinol, Epub ahead of print, 2011.Simon R. Challenges of microarray data and the evaluation of gene expression profile signatures.Cancer Invest, 26, 327–332, 2008.Singh RR, Cheung KJ, Horsman DE. Utility of Array Comparative Genomic Hybridization inCytogenetic Analysis. Methods Mol Biol, 730, 219-234, 2011.Skubitz KM and Skubitz AP. Differential gene expression in uterine leiomyoma. J Lab Clin Med,141,297-308, 2003.Skubitz KM and Skubitz APN. Differential Gene Expression in Leiomyosarcoma. Cancer, 98, 5, 1029-1038, 2003.Sleeman MA, Fraser JK, Murison JG et al. B cell- and monocyte-activating chemokine (BMAC), anovel non-ELR alpha-chemokine. Int Immunol, 12, 677-689, 2000.Slovak ML, Bedell V, Hsu YH et al. Hodgkin and Reed-Sternberg cells at disease onset harbor distinctrecurring DNA copy number alterations in chemosensitive versus primary refractoryHodgkin lymphoma. Clin Cancer Res, Epub ahead of print, 2011.Smith SW, Eardley KS, Croft AP et al. CD248(+) stromal cells are associated with progressivechronic kidney disease. Kidney Int, Epub ahead of print, 2011.
Cirilo, PDRREFERÊNCIAS228Solyom S, Winqvist R, Nikkilä J et al. Screening for large genomic rearrangements in the FANCAgene reveals extensive deletion in a Finnish breast cancer family. Cancer Lett, 28, 113-118,2011.Sorlie T, Tibshirani R, Parker J et al. Repeated observation of breast tumor subtypes in independentgene expression data sets. Proc Natl Acad Sci USA, 100, 8418–8423, 2003.Sornberger KS, Weremowicz S, Williams AJ et al. Expression of HMGIY in three uterine leiomyomatawith complex rearrangements of chromosome 6. Cancer Genet Cytogenet, 114, 9-16, 1999.Sotiriou C, Neo SY, McShane LM et al. Breast cancer classification and prognosis based on geneexpression profiles from a population-based study. Proc Natl Acad Sci USA, 100, 10393–10398, 2003.Sourla A, Polychronakos C, Zeng WR. Plasminogen activator inhibitor 1 messenger RNA expressionand molecular evidence for del (7) (q22) in uterine leiomyomas. Cancer Res, 56, 3123–3128,1996.Sozen I and Arici A. Interactions of cytokines, growth factors, and the extracellular matrix in thecellular biology of uterine leiomyomata. Fertil Steril, 78, 1-12, 2002.Spivey KA and Banyard J. A prognostic gene signature in advanced ovarian cancer reveals amicrofibril-associated protein (MAGP2) as a promoter of tumor cell survival andangiogenesis. Cell Adh Migr, 4, 169-171, 2010.Steck PA, Pershouse MA, Jasser SA. Identification of a candidate tumour suppressor gene, MMAC1,at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet, 15, 356-362, 1997.Steiner E, Holzmann K, Elbling L et al. Cellular functions of vaults and their involvement inmultidrug resistance. Curr Drug Targets, 7, 923-934, 2006.Stewart EA and Nowak RA. New concepts in the treatment of uterine leiomyomas. Obstet Gynecol,92, 24-27, 1998.Stewart EA, Friedman AJ, Peck K et al. Relative overexpression of collagen type I and collagen typeIII messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of themenstrual cycle. J Clin Endocrinol Metab, 79, 900–906, 1994.Stewart L, Glenn GM, Stratton P et al. Association of germline mutations in the fumarate hydratasegene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer.Arch Dermatol, 144, 1584-1592, 2008.Stovall DW. Clinical symptomatology of uterine leiomyomas. Clin Obstet Gynecol, 44, 364-371,2001.Strissel PL, Swiatek J, Oppelt P et al. Transcriptional analysis of steroid hormone receptors insmooth muscle uterine leiomyoma tumors of postmenopausal patients. J Steroid BiochemMol Biol, 107, 42-47, 2007.
- Page 199 and 200: Cirilo, PDRDISCUSSÃO176regiões de
- Page 201 and 202: Cirilo, PDRDISCUSSÃO178da RNA Pol
- Page 203 and 204: Cirilo, PDRDISCUSSÃO180proliferati
- Page 205 and 206: Cirilo, PDRDISCUSSÃO182Entre os 20
- Page 207 and 208: Cirilo, PDRDISCUSSÃO184propôs um
- Page 209 and 210: Cirilo, PDRDISCUSSÃO186analisados
- Page 211 and 212: Cirilo, PDRDISCUSSÃO188observados
- Page 213 and 214: Cirilo, PDRDISCUSSÃO190moduladores
- Page 215 and 216: Cirilo, PDRDISCUSSÃO192genômica/d
- Page 217 and 218: Cirilo, PDRDISCUSSÃO194identificar
- Page 219 and 220: Cirilo, PDRDISCUSSÃO196e também d
- Page 221 and 222: Cirilo, PDRDISCUSSÃO198O gene COL3
- Page 223 and 224: Cirilo, PDRDISCUSSÃO200resistênci
- Page 225 and 226: Cirilo, PDRDISCUSSÃO202bioquímica
- Page 227 and 228: Cirilo, PDRDISCUSSÃO204carcinoma c
- Page 229 and 230: Cirilo, PDRCONCLUSÕES DISCUSSÃO20
- Page 231 and 232: Cirilo, PDRREFERÊNCIAS2087. Refer
- Page 233 and 234: Cirilo, PDRREFERÊNCIAS210Brazelle
- Page 235 and 236: Cirilo, PDRREFERÊNCIAS212Churikov
- Page 237 and 238: Cirilo, PDRREFERÊNCIAS214Gannon BR
- Page 239 and 240: Cirilo, PDRREFERÊNCIAS216Holthause
- Page 241 and 242: Cirilo, PDRREFERÊNCIAS218Kazmiercz
- Page 243 and 244: Cirilo, PDRREFERÊNCIAS220Lloret M,
- Page 245 and 246: Cirilo, PDRREFERÊNCIAS222Mitra R,
- Page 247 and 248: Cirilo, PDRREFERÊNCIAS224Ozisik YY
- Page 249: Cirilo, PDRREFERÊNCIAS226Redon R,
- Page 253 and 254: Cirilo, PDRREFERÊNCIAS230Ueki K, R
- Page 255 and 256: Cirilo, PDRREFERÊNCIAS232and poly(
- Page 257 and 258: Skubitz KM e Skubitz APJ Lab Clin M
- Page 259 and 260: Dimitrova IK et al. Fertil Steril,9
- Page 261 and 262: 317T_B317T_C13 614T 44 LU prolifera
- Page 263 and 264: 46 867T 46 LUM outros B 14 33,5 17
- Page 265 and 266: 1015T 6q13-q14.1 75,806,978-76,314,
- Page 267 and 268: MRPS31, SLC25A15, SUGT1L1 320d-1630
- Page 269 and 270: 8q22.3-q23.1 105,831,966 107,742,33
- Page 271 and 272: Anexo 5. Genes identificados na an
- Page 273 and 274: + + CCDC8 0 51 37 14+ - CALM3 51 0
- Page 275 and 276: ABSTRACTBackground: Uterine leiomyo
- Page 277 and 278: Thus, these findings prompt us to i
- Page 279 and 280: Technologies, Santa Clara, CA). Sta
- Page 281 and 282: mapped at 1p36.13, 1q41, 2q32.1, 2q
- Page 283 and 284: genetic disorder showed the higher
- Page 285 and 286: The modulators were mainly associat
- Page 287 and 288: egulation of cell cycle. Chegini an
- Page 289 and 290: REFERENCES[1] Baird DD, Dunson DB (
- Page 291 and 292: [37] Luo X, Ding L, Xu J et al. (20
- Page 293 and 294: AArray CGHExpression arrayBtumoral
- Page 295 and 296: ABDiseases and Disorders P value Mo
- Page 298 and 299: Tabel 2. Genes identified on module
Cirilo, PDRREFERÊNCIAS227Scherer SW, Cheung J, MacDonald JR et al. Human chromosome 7: DNA sequence and biology.Science, 300, 767-772, 2003.Schwartz SM. Epi<strong>de</strong>miology of uterine leiomyomata. Clin Obst Gynecol, 44, 316-326, 2001.Segal E, Shapira M, Regev A et al. Module networks: i<strong>de</strong>ntifying regulatory modules and theircondition-specific regulators from gene expression data. Nat Genetics, 34, 166-176, 2003.Sell SM, Tullis C, Stracner D et al. Minimal interval <strong>de</strong>fined on 7q in uterine leiomyoma. CancerGenet Cytogenetics, 157, 67–69, 2005.Sen<strong>de</strong>mir A, Sen<strong>de</strong>mir E, Kosmehl H et al. Expression of sex hormone-binding globulin, oxytocinreceptor, caveolin-1 and p21 in leiomyoma. Gynecol Endocrinol, 24, 105-112, 2008.Shaw-Smith C, Redon R, Rickman L et al. Microarray based comparative genomic hybridization(array-CGH) <strong>de</strong>tects submicroscopic chromosomal <strong>de</strong>letions and duplications in patientswith learning disability/mental retardation and dysmorphic features. J Med Genet, 41, 241–248, 2004.Shiang CY, Qi Y, Wang B et al. Amplification of fibroblast growth factor receptor-1 in breast cancerand the effects of brivanib alaninate. Breast Cancer Res Treat, 123, 747-755, 2010.Shozu M, Sumitani H, Segawa T et al. Overexpression of aromatase P450 in leiomyoma tissue isdriven primarily through promoter I.4 of the aromatase P450 gene (CYP19). J ClinEndocrinol Metab, 87, 2540-2548, 2002.Shaik NA, Lone WG, Khan IA et al. Enhanced transcription of estrogen receptor α and mitochondrialcytochrome b genes in uterine leiomyomas. Gynecol Endocrinol, Epub ahead of print, 2011.Simon R. Challenges of microarray data and the evaluation of gene expression profile signatures.Cancer Invest, 26, 327–332, 2008.Singh RR, Cheung KJ, Horsman DE. Utility of Array Comparative Genomic Hybridization inCytogenetic Analysis. Methods Mol Biol, 730, 219-234, 2011.Skubitz KM and Skubitz AP. Differential gene expression in uterine leiomyoma. J Lab Clin Med,141,297-308, 2003.Skubitz KM and Skubitz APN. Differential Gene Expression in Leiomyosarcoma. Cancer, 98, 5, 1029-1038, 2003.Sleeman MA, Fraser JK, Murison JG et al. B cell- and monocyte-activating chemokine (BMAC), anovel non-ELR alpha-chemokine. Int Immunol, 12, 677-689, 2000.Slovak ML, Be<strong>de</strong>ll V, Hsu YH et al. Hodgkin and Reed-Sternberg cells at disease onset harbor distinctrecurring DNA copy number alterations in chemosensitive versus primary refractoryHodgkin lymphoma. Clin Cancer Res, Epub ahead of print, 2011.Smith SW, Eardley KS, Croft AP et al. CD248(+) stromal cells are associated with progressivechronic kidney disease. Kidney Int, Epub ahead of print, 2011.